Literature DB >> 25564591

Anti-MuSK-positive myasthenia gravis diagnosed during pregnancy: new challenges for an old disease?

Ana Raquel Neves1, Pitorra Monteiro1, Anabela Matos2, Isabel Santos Silva1.   

Abstract

Myasthenia gravis is an autoimmune disorder affecting predominantly women in their reproductive age. The course of the disease during pregnancy is unpredictable, although it is more difficult to manage earlier in the gestation. Myasthenia gravis with antibodies against the muscle-specific receptor tyrosine kinase (anti-MuSK) has been described as a subtype of disease with more localised clinical features and a poorer response to treatment than acetylcholine receptor antibody (anti-AChR)-positive patients. Few cases have been reported in pregnant women, with deliveries being performed mainly by caesarean section. We report a successful case of vaginal delivery and describe our experience providing the first review of the management of this subtype of disease during pregnancy. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25564591      PMCID: PMC4289748          DOI: 10.1136/bcr-2014-207708

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  26 in total

Review 1.  Myasthenia gravis during pregnancy.

Authors:  Simone Ferrero; Francesca Esposito; Mariangela Biamonti; Giorgio Bentivoglio; Nicola Ragni
Journal:  Expert Rev Neurother       Date:  2008-06       Impact factor: 4.618

2.  A transient neonatal myasthenic syndrome with anti-musk antibodies.

Authors:  E H Niks; A Verrips; B A Semmekrot; M J J Prick; A Vincent; M J D van Tol; C M Jol-van der Zijde; J J G M Verschuuren
Journal:  Neurology       Date:  2008-04-01       Impact factor: 9.910

Review 3.  Myasthenia gravis and pregnancy.

Authors:  Michael Varner
Journal:  Clin Obstet Gynecol       Date:  2013-06       Impact factor: 2.190

Review 4.  Corticosteroids for myasthenia gravis.

Authors:  C Schneider-Gold; P Gajdos; K V Toyka; R R Hohlfeld
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

5.  Response to therapy in myasthenia gravis with anti-MuSK antibodies.

Authors:  Amelia Evoli; Maria R Bianchi; Raffaella Riso; Giacomo M Minicuci; Anna P Batocchi; Serenella Servidei; Flavia Scuderi; Emanuela Bartoccioni
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

Review 6.  Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.

Authors:  Angela Vincent; John Bowen; John Newsom-Davis; John McConville
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

7.  Myasthenia gravis during pregnancy.

Authors:  Shahnaz Akhtar Chaudhry; Biruthvie Vignarajah; Gideon Koren
Journal:  Can Fam Physician       Date:  2012-12       Impact factor: 3.275

Review 8.  [Antibodies in myasthenia gravis].

Authors:  B Eymard
Journal:  Rev Neurol (Paris)       Date:  2009-01-21       Impact factor: 2.607

9.  Myasthenia gravis: a review of available treatment approaches.

Authors:  Nils Erik Gilhus; Jone F Owe; Jana Midelfart Hoff; Fredrik Romi; Geir Olve Skeie; Johan A Aarli
Journal:  Autoimmune Dis       Date:  2011-10-05

10.  Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.

Authors:  Shin Joong Oh
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more
  1 in total

1.  Emergency Caesarean Section Saved Both an Anti-MuSK Antibody-positive Myasthenia Gravis Mother with Pregnancy-induced Hypertension and Her Premature Baby.

Authors:  Yoshiaki Takahashi; Toru Yamashita; Ryuta Morihara; Yumiko Nakano; Kota Sato; Mami Takemoto; Nozomi Hishikawa; Yasuyuki Ohta; Kei Hayata; Hisashi Masuyama; Tomoka Okamura; Yosuke Washio; Koji Abe
Journal:  Intern Med       Date:  2017-10-16       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.